Browsing by Author "Gatselis, N."
Now showing items 21-39 of 39
-
Long term efficacy of Interferon a-2b/Peg-Iinterferon a-2b monotherapy in b-thalassemics with chronic hepatitis C
Triantos, C. K.; Kourakli, A.; Gatselis, N.; Kalafateli, M.; Lambropoulou, P.; De Lastic, A. L.; Thomopoulos, K.; Tsamandas, A.; Christofidou, M.; Jelastopulu, E.; Nikolopoulou, V.; Symeonidis, A.; Dalekos, G. N.; Labropoulou-Karatza, C. C. (2013) -
MYCOPHENOLATE FOR AUTOIMMUNE HEPATITIS TREATMENT: PROSPECTIVE ASSESSMENT OF ITS EFFICACY AND SAFETY FOR INDUCTION AND MAINTENANCE OF REMISSION IN A LARGE COHORT OF TREATMENT-NAIVE PATIENTS
Zachou, K.; Gatselis, N.; Papadamou, G.; Rigopoulou, E. I.; Dalekos, G. N. (2011) -
Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients
Zachou, K.; Gatselis, N.; Papadamou, G.; Rigopoulou, E. I.; Dalekos, G. N. (2011)Background & Aims: Standard therapy for autoimmune hepatitis (AIH) is corticosteroids with or without azathioprine. However, 20% of patients do not respond or are intolerant to conventional treatment. Therefore, we evaluated ... -
Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients
Zachou, K.; Gatselis, N.; Papadamou, G.; Rigopoulou, E. I.; Dalekos, G. N. (2011)Background & Aims: Standard therapy for autoimmune hepatitis (AIH) is corticosteroids with or without azathioprine. However, 20% of patients do not respond or are intolerant to conventional treatment. Therefore, we evaluated ... -
Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: A case series
Tsironi, E.; Gatselis, N.; Kotoula, M. G.; Zachou, K.; Pefkianaki, M.; Zacharaki, F.; Chatzoulis, D. Z.; Dalekos, G. N. (2009)Introduction: Antiphospholipid syndrome is an autoimmune disorder characterized by either a history of vascular thrombosis (one or more clinical episodes of arterial, venous, or small vessel thrombosis in any tissue or ... -
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases
Zachou, K.; Liaskos, C.; Rigopoulou, E.; Gabeta, S.; Papamichalis, P.; Gatselis, N.; Georgiadou, S.; Dalekos, G. N. (2006)We studied the prevalence and clinical significance of anticardiolipin antibodies (aCL) in primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) as similar data are missing. Ninety-nine PBC patients, 41 ... -
Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis
Liaskos, C.; Rigopoulou, E.; Zachou, K.; Georgiadou, S.; Gatselis, N.; Papamihali, R.; Dalekos, G. N. (2005)There are few case reports on the association between autoimmune hepatitis (AIH) and anticardiolipin antibodies (anti-CLAbs) and/or antiphospholipid syndrome (APLS). We studied the anti-CLAbs prevalence in AIH and other ... -
Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients
Zografos, T. A.; Gatselis, N.; Zachou, K.; Liaskos, C.; Gabeta, S.; Koukoulis, G. K.; Dalekos, G. N. (2012)AIM: To determine the prevalence and significance of primary biliary cirrhosis (PBC)-specific autoantibodies in first-degree relatives (FDRS) of Greek PBC patients. METHODS: The presence of antimitochondrial antibodies ... -
Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis
Satra, M.; Gatselis, N.; Iliopoulos, D.; Zacharoulis, D.; Dalekos, G. N.; Tsezou, A. (2007)We determined, for the first time, the human telomerase reverse transcriptase (hTERT) mRNA expression, using real-time quantitative PCR, in liver tissues from patients with hepatocellular cancer (HCC; n = 13), chronic ... -
Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: A case report and review of the literature
Tzovaras, N.; Stefos, A.; Georgiadou, S. P.; Gatselis, N.; Papadamou, G.; Rigopoulou, E.; Ioannou, M.; Skoularigis, I.; Dalekos, G. N. (2006)Hepatopulmonary syndrome (HPS) is defined as a clinical triad including liver disease, abnormal pulmonary gas exchange and evidence of intrapulmonary vascular dilatations. We report a 61-year-old male presented with fatigue, ... -
Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: A case report and review of the literature
Tzovaras, N.; Stefos, A.; Georgiadou, S. P.; Gatselis, N.; Papadamou, G.; Rigopoulou, E.; Ioannou, M.; Skoularigis, I.; Dalekos, G. N. (2005)Hepatopulmonary syndrome (HPS) is defined as a clinical triad including liver disease, abnormal pulmonary gas exchange and evidence of intrapulmonary vascular dilatations. We report a 61-year-old male presented with fatigue, ... -
Review article: autoimmune hepatitis - current management and challenges
Zachou, K.; Muratori, P.; Koukoulis, G. K.; Granito, A.; Gatselis, N.; Fabbri, A.; Dalekos, G. N.; Muratori, L. (2013)BackgroundAutoimmune hepatitis (AIH) is a disease of unknown aetiology characterised by interface hepatitis, hypergammaglobulinaemia, circulating autoantibodies and a favourable response to immunosuppression. AimTo review ... -
Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)
Papatheodoridis, G. V.; Dalekos, G. N.; Yurdaydin, C.; Goulis, I.; Arends, P.; Buti, M.; Sypsa, V.; Manolakopoulos, S.; Mangia, G.; Gatselis, N.; Keskin, O.; Savvidou, S.; Hansen, B. E.; Papaioannou, C.; Galanis, K.; Idilman, R.; Colombo, M.; Esteban, R.; Janssen, H. L.; Lampertico, P. (2013) -
Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome
Kapsalaki, E.; Gatselis, N.; Stefos, A.; Makaritsis, K.; Vassiou, A.; Fezoulidis, I.; Dalekos, G. N. (2009)Background: Spontaneous spondylodiscitis is an uncommon disease, which may result in serious complications with potentially high morbidity and mortality. We conducted a prospective case study over a 2-year period in order ... -
Timing of hepatocellular carcinoma (HCC) development and predictability of a modified PAGE-B risk score in caucasian chronic hepatitis B (CHB) patients treated with entecavir (ETV) or tenofovir (TDF)
Papatheodoridis, G. V.; Dalekos, G. N.; Sypsa, V.; Yurdaydin, C.; Buti, M.; Goulis, I.; Chi, H.; Manolakopoulos, S.; Mangia, G.; Gatselis, N.; Keskin, O.; Savvidou, S.; Hansen, B. E.; Vlachogiannakos, J.; Galanis, K.; Idilman, R.; Colombo, M.; Esteban, R.; Janssen, H. L.; Lampertico, P. (2014) -
Unexplained choroidal embolisation: remember the antiphospholipid syndrome
Tsironi, E.; Gatselis, N.; Kotoula, M. G.; Chatzoulis, D. Z.; Dalekos, G. N. (2006) -
A unique case of Henoch-Schonlein purpura in a very old woman
Barbanis, S.; Karasavvidou, F.; Gatselis, N.; Pappa, D.; Papamichali, R.; Dalekos, G. (2008) -
Use of TNF alpha antagonists in refractory AIH: Revealing the unforeseen
Saitis, A.; Gatselis, N.; Zachou, K.; Dalekos, G. N. (2013) -
Use of TNFα antagonists in refractory AIH: Revealing the unforeseen
Saitis, A.; Gatselis, N.; Zachou, K.; Dalekos, G. N. (2013)